• The New Money
  • Posts
  • The Public Company Disrupting Drug Discovery With AMD, The U.S. Army Is Going 3D, And Humanoid Robots Hit The Factory Floor

The Public Company Disrupting Drug Discovery With AMD, The U.S. Army Is Going 3D, And Humanoid Robots Hit The Factory Floor

The markets and trends that matter, made simple. Discover what’s next.

The Public Company Partnering Up With AMD To Disrupt Drug Discovery

MindWalk Holdings (NASDAQ: HYFT) is leveraging Advanced Micro Devices’ (NASDAQ: AMD) hardware and software for artificial intelligence workloads to run large biology models and accelerate potential breakthroughs in drug discovery. And now, they’ve successfully identified a single, shared functional constraint in influenza that is present across human, avian and swine strains of Influenza A and Influenza B.

The U.S. Army Is Partnering Up With Velo3D

Velo3D (NASDAQ: VELO) entered into a new deal with the United States Army DEVCOM Ground Vehicle Systems Centre to develop 3D printed metal parts for ground combat vehicles. Velo3D has publicly stated the new 3D printed materials will be produced completely in America and is part of the United States Army’s effort to strengthen their domestic supply chain for ground combat vehicles.

An Automotive Manufacturing Giant Is Deploying Humanoid Robots

Automotive company Schaeffler formed a new partnership with Humanoid to begin deploying hundreds of humanoid robots into their factories globally. Schaeffler has publicly stated they are aiming to both deploy humanoid robots at scale within their own operations as well as becoming a leading supplier of bearings, rotary gearboxes, electric motors and other hardware components for companies developing humanoid robots.

The Eric Jackson Interview: Overlooked Opportunities And Hunting The Next 100X

Eric Jackson is a contrarian tech investor and founder of EMJ Capital. Known for spotting disruptive growth opportunities early and championing retail investors, Jackson has earned a reputation for bold calls—like predicting Carvana's turnaround and driving rallies in stocks such as Opendoor.

Discover the world’s most exciting stocks, easier than ever before. Download The New Money App.

The Sprint

Looking to connect? Reach out and get in touch.

New here? Join our community of 100,000+ individuals interested in uncovering the world’s most exciting early stage companies.

Disclaimer: The New Money provides background information on early stage companies from publicly available sources. The New Money provides no advice on dealing in securities, is not a financial adviser and does not pretend to be so. This message is meant for information and educational purposes only. The information contained in this email is not to be considered factual or complete. Anybody interested in obtaining financial and other information on companies mentioned is advised to get it direct from the companies, or from their own investment adviser. The New Money does not intend for this information to be used to inform an investment decision. The New Money has been compensated by some of the companies mentioned in this email for awareness campaigns, which affects our ability to be unbiased. The Principals of The New Money may buy or sell shares of the mentioned companies without further notice. This is why we stress that you conduct extensive due diligence as well as seek the advice of your financial advisor or a registered broker-dealer before investing in any securities. The New Money and its principals and agents are not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Always do your own research and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment. Investing is inherently risky. While a potential for rewards exists, by investing, you are putting yourself at risk. You must be aware of the risks and be willing to accept them in order to invest in any type of security. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy or Sell securities. No representation is being made that any stock trade will or is likely to achieve profits. Comparisons made to other featured companies or past performance is not indicative of future results.